gastric-cancer

Documents about gastric-cancer

• Completion of perioperative chemotherapy and tumor regression grade as independent predictors of one-year survival after total gastrectomy for gastric cancer: a retrospective cohort study#202231Europe PMC
• How to best exploit immunotherapeutics in advanced gastric cancer: between biomarkers and novel cell-based approaches#250634IRIS
• Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062)#994279ClinicalTrials.gov
• Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial#811593ClinicalTrials.gov
• Toripalimab Combined With Anlotinib for Patients With Advanced, Relapsed, or Refractory Gastric, or Esophagogastric Junction Cancer (EGJC)#838606ClinicalTrials.gov
• Spatio-temporal changes in clusters of gastric cancer incidence: The impact of nationwide cancer control programs in South Korea#285432PLOS
• Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy#828541ClinicalTrials.gov
• Ivonescimab (AK112) Plus Paclitaxel as Second-line Therapy in Patients With Advanced G/GEJ Cancer#287562ClinicalTrials.gov
• Chilean Association of Digestive Endoscopy (ACHED) guidelines for the detection of early gastric cancer and surveillance of gastric premalignant conditions in high-risk populations#260588Repositorio USS
• Study of S1 Efficacy and Toxicity as Second-line Treatment on Inoperable or Advanced Gastric Cancers#893517ClinicalTrials.gov
• Financial Navigation Intervention in Improving Financial and Clinical Outcomes in Patients With Newly Diagnosed Gastric or Gastroesophageal Junction Adenocarcinoma#994469ClinicalTrials.gov
• Gastric cancer: French intergroup clinical practice guidelines for diagnosis, staging, treatment and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACHBPT, RENAPE, SNFCP)#227016HAL (France)
• A Real-World, Single-Arm Study Protocol of Disitamab Vedotin in Combination With Immunotherapy and Multimodal Radiation Therapy for HER2-Positive Advanced Gastric Cancer: After Second-Line Treatment Failure#230390ClinicalTrials.gov
• A Prospective and Observational Cohort Study to Evaluate the Treatment Model and Medical Economics of Advanced Gastric Cancer Chemotherapy in Clinical Practice in China#827179ClinicalTrials.gov
• Efficacy and Safety Study of Endoscopic Submucosal Dissection for Early Gastric Cancer#857170ClinicalTrials.gov
• Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors#245375ClinicalTrials.gov
• 4SCAR-CD44v6 T Cell Therapy Targeting Cancer#856288ClinicalTrials.gov
• Safety and Feasibility of Reversible Induction Strategy#887563ClinicalTrials.gov
• Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients#899865ClinicalTrials.gov
• Surgical Conversion of Candonilimab (AK104) Plus Paclitaxel, S-1 and Apatinib for Unresectable Advanced G/GEJ Cancer#911992ClinicalTrials.gov
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors#812342ClinicalTrials.gov
• Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer#862787ClinicalTrials.gov
• Distance-Based Exercise to Preserve Function and Prevent Disability#851881ClinicalTrials.gov
• Guaraná Supplementation for Cancer-Related Fatigue#864728ClinicalTrials.gov
• Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer#901300ClinicalTrials.gov
• Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract#813325ClinicalTrials.gov
• A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment Characteristics#833363ClinicalTrials.gov
• A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors#893583ClinicalTrials.gov
• Advanced Gastrointestinal Endoscopic Imaging#808043ClinicalTrials.gov
• ILF With/Without Cisplatin for Advanced Gastric Cancer#810071ClinicalTrials.gov
• Early Jejunostomy Nutrition Minimizes Time to Chemotherapy#832938ClinicalTrials.gov
• A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer#981875ClinicalTrials.gov
• Study of IBI363 in Patients with Advanced First-line Gastric Cancer#1007594ClinicalTrials.gov
• Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE#810478ClinicalTrials.gov
• To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.#871976ClinicalTrials.gov
• Safety and Efficacy of OGT Method Versus the Traditional Overlap Method#911885ClinicalTrials.gov
• Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer#804129ClinicalTrials.gov
• DURATION-GC: FLOT Plus Durvalumab and TS-1 Plus Durvalumab for Resectable Gastric Cancer#872391ClinicalTrials.gov
• Lymph Node Metastasis in Extended Lymphadenectomy for Gastric Cancer From a CLASSIC Trial#876994ClinicalTrials.gov
• Laparoscopic Versus Open Lower Mediastinal Lymphadenectomy for Esophagogastric Junction Cancer#906257ClinicalTrials.gov
• Application of Indocyanine Green Tracer in D2 Lymphadenectomy of Locally Advanced Gastric Cancer#891836ClinicalTrials.gov
• Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients#908834ClinicalTrials.gov
• Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients#387151ClinicalTrials.gov
• ASKB589 in Combination With CAPOX and PD-1 Inhibitors in Patients With Advanced, and Unresectable G/GEJ Cancer.#839373ClinicalTrials.gov
• Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction，a Phase II Clinical Study#825470ClinicalTrials.gov
• Effect of Multi-modal Intervention Care on Cachexia in Patients With Advanced Cancer Compared to Conventional Management (MIRACLE)#891984ClinicalTrials.gov
• Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma#871703ClinicalTrials.gov
• Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)#261506ClinicalTrials.gov
• The Effect of Braun Anastomosis on Delayed Gastric Emptying (DGE) in Reconstruction After Pancreaticoduodenectomy#806339ClinicalTrials.gov
• Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy#853074ClinicalTrials.gov